Prestige Consumer Healthcare Inc. (FRA:PBV)
Germany · Delayed Price · Currency is EUR 50.50
0.00 (0.00%)
At close: Nov 28, 2025
FRA:PBV Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 1,109 | 1,137 | 1,125 | 1,128 | 1,087 | 943.32 | Upgrade |
Other Revenue | 1.24 | 1.18 | 0.31 | 0.11 | 0.04 | 0.04 | Upgrade |
| 1,110 | 1,138 | 1,125 | 1,128 | 1,087 | 943.37 | Upgrade | |
Revenue Growth (YoY) | -0.02% | 1.10% | -0.21% | 3.76% | 15.21% | -2.04% | Upgrade |
Cost of Revenue | 478.44 | 494.42 | 492.79 | 494.88 | 458.94 | 389.67 | Upgrade |
Gross Profit | 632.04 | 643.35 | 632.57 | 632.84 | 627.87 | 553.7 | Upgrade |
Selling, General & Admin | 258.31 | 263.93 | 259.47 | 252.42 | 259.7 | 223.7 | Upgrade |
Operating Expenses | 287.76 | 294.11 | 290.14 | 285.04 | 291.79 | 253.86 | Upgrade |
Operating Income | 344.28 | 349.24 | 342.43 | 347.8 | 336.08 | 299.84 | Upgrade |
Interest Expense | -42.45 | -47.63 | -67.16 | -69.16 | -64.29 | -82.33 | Upgrade |
Other Non Operating Income (Expenses) | -4.34 | -4.95 | 0.76 | -2.34 | -1.05 | 1.37 | Upgrade |
EBT Excluding Unusual Items | 297.49 | 296.66 | 276.03 | 276.3 | 270.74 | 218.87 | Upgrade |
Merger & Restructuring Charges | - | - | - | - | -5.1 | - | Upgrade |
Impairment of Goodwill | - | - | - | -48.8 | -0.3 | -1.25 | Upgrade |
Asset Writedown | -12.47 | -12.47 | - | -321.42 | -0.76 | -1.19 | Upgrade |
Other Unusual Items | - | - | - | - | -2.12 | -12.33 | Upgrade |
Pretax Income | 285.02 | 284.19 | 276.03 | -93.92 | 262.46 | 204.11 | Upgrade |
Income Tax Expense | 84.19 | 69.58 | 66.69 | -11.61 | 57.08 | 39.43 | Upgrade |
Net Income | 200.84 | 214.61 | 209.34 | -82.31 | 205.38 | 164.68 | Upgrade |
Net Income to Common | 200.84 | 214.61 | 209.34 | -82.31 | 205.38 | 164.68 | Upgrade |
Net Income Growth | -2.48% | 2.52% | - | - | 24.71% | 15.74% | Upgrade |
Shares Outstanding (Basic) | 49 | 50 | 50 | 50 | 50 | 50 | Upgrade |
Shares Outstanding (Diluted) | 50 | 50 | 50 | 50 | 51 | 51 | Upgrade |
Shares Change (YoY) | -0.77% | -0.19% | 0.58% | -1.87% | 0.47% | -1.05% | Upgrade |
EPS (Basic) | 4.06 | 4.32 | 4.21 | -1.65 | 4.09 | 3.28 | Upgrade |
EPS (Diluted) | 4.04 | 4.29 | 4.17 | -1.65 | 4.04 | 3.25 | Upgrade |
EPS Growth | -1.41% | 2.88% | - | - | 24.31% | 16.91% | Upgrade |
Free Cash Flow | 255.45 | 243.29 | 239.38 | 221.93 | 250.28 | 213.36 | Upgrade |
Free Cash Flow Per Share | 5.13 | 4.86 | 4.77 | 4.45 | 4.92 | 4.22 | Upgrade |
Gross Margin | 56.92% | 56.55% | 56.21% | 56.12% | 57.77% | 58.69% | Upgrade |
Operating Margin | 31.00% | 30.70% | 30.43% | 30.84% | 30.92% | 31.78% | Upgrade |
Profit Margin | 18.09% | 18.86% | 18.60% | -7.30% | 18.90% | 17.46% | Upgrade |
Free Cash Flow Margin | 23.00% | 21.38% | 21.27% | 19.68% | 23.03% | 22.62% | Upgrade |
EBITDA | 373.73 | 379.41 | 373.1 | 380.43 | 368.17 | 330 | Upgrade |
EBITDA Margin | 33.66% | 33.35% | 33.15% | 33.73% | 33.88% | 34.98% | Upgrade |
D&A For EBITDA | 29.45 | 30.17 | 30.68 | 32.63 | 32.09 | 30.16 | Upgrade |
EBIT | 344.28 | 349.24 | 342.43 | 347.8 | 336.08 | 299.84 | Upgrade |
EBIT Margin | 31.00% | 30.70% | 30.43% | 30.84% | 30.92% | 31.78% | Upgrade |
Effective Tax Rate | 29.54% | 24.48% | 24.16% | - | 21.75% | 19.32% | Upgrade |
Revenue as Reported | 1,110 | 1,138 | 1,125 | 1,128 | 1,087 | 943.37 | Upgrade |
Advertising Expenses | - | 155.72 | 153.32 | 145.06 | 157.34 | 140.59 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.